Aspiriant LLC’s Zimmer Biomet ZBH Stock Holding History

Aspiriant LLC’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,827	Closed	-$266K	–	297
2023 Q2	$266K	Hold	1,827	–	–	0.01%	242
2023 Q1	$236K	Hold	1,827	–	–	0.01%	248
2022 Q4	$233K	Buy	+1,827	New	+$212K	0.01%	243

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aspiriant LLC's ZBH Position: Q3 2023 in Review

Aspiriant LLC sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,827 shares — an estimated $266K sold.

Aspiriant LLC first reported a position in ZBH in Q4 2022 and held it in 3 quarters. The position peaked at $266K in Q2 2023. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Aspiriant LLC reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Aspiriant LLC sold 1,827 Zimmer Biomet shares in Q3 2023, an estimated $266K.
Aspiriant LLC first reported a position in Zimmer Biomet in Q4 2022 and held it in 3 quarters.
Aspiriant LLC's Zimmer Biomet position peaked at $266K in Q2 2023.
1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Aspiriant LLC's 13F filing for Q3 2023, filed 18 Oct 2023.